- Home
- AMRX vs SBLK Comparison
AMRX vs SBLK Comparison
Compare AMRX & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- SBLK
- Stock Information
- Founded
- AMRX 2002
- SBLK 2006
- Country
- AMRX United States
- SBLK Greece
- Employees
- AMRX N/A
- SBLK N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- SBLK Marine Transportation
- Sector
- AMRX Health Care
- SBLK Consumer Discretionary
- Exchange
- AMRX Nasdaq
- SBLK Nasdaq
- Market Cap
- AMRX 2.3B
- SBLK 1.9B
- IPO Year
- AMRX N/A
- SBLK N/A
- Fundamental
- Price
- AMRX $7.32
- SBLK $16.51
- Analyst Decision
- AMRX Strong Buy
- SBLK Strong Buy
- Analyst Count
- AMRX 4
- SBLK 3
- Target Price
- AMRX $11.50
- SBLK $22.67
- AVG Volume (30 Days)
- AMRX 1.9M
- SBLK 1.2M
- Earning Date
- AMRX 05-02-2025
- SBLK 05-14-2025
- Dividend Yield
- AMRX N/A
- SBLK 8.72%
- EPS Growth
- AMRX N/A
- SBLK N/A
- EPS
- AMRX N/A
- SBLK 1.96
- Revenue
- AMRX $2,830,186,000.00
- SBLK $1,236,718,000.00
- Revenue This Year
- AMRX $10.20
- SBLK N/A
- Revenue Next Year
- AMRX $7.15
- SBLK $17.42
- P/E Ratio
- AMRX N/A
- SBLK $8.40
- Revenue Growth
- AMRX 13.42
- SBLK 25.60
- 52 Week Low
- AMRX $6.29
- SBLK $12.06
- 52 Week High
- AMRX $9.48
- SBLK $27.39
- Technical
- Relative Strength Index (RSI)
- AMRX 46.61
- SBLK 62.67
- Support Level
- AMRX $7.02
- SBLK $15.82
- Resistance Level
- AMRX $7.39
- SBLK $16.35
- Average True Range (ATR)
- AMRX 0.18
- SBLK 0.40
- MACD
- AMRX -0.00
- SBLK -0.01
- Stochastic Oscillator
- AMRX 45.80
- SBLK 55.30
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.